advertisement

---

Sato K 17

Showing records 1 to 17 | Display all abstracts from Sato K

84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Yamamoto K
Scientific reports 2019; 9: 19288

---

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Sato K
Current Eye Research 2020; 0: 1-10

---

84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Yabana T; Sato K
PLoS ONE 2019; 14: e0227078

---

84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Kokubun T
Scientific reports 2019; 9: 19288

---

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Nakagawa Y; Omodaka K
Current Eye Research 2020; 0: 1-10

---

84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Sato K
Scientific reports 2019; 9: 19288

---

84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Shiga Y; Himori N
PLoS ONE 2019; 14: e0227078

---

84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Akaishi T
Scientific reports 2019; 9: 19288

---

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Asada H
Current Eye Research 2020; 0: 1-10

---

84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shimazaki A
Scientific reports 2019; 9: 19288

---

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Fujii S
Current Eye Research 2020; 0: 1-10

---

84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Omodaka K
PLoS ONE 2019; 14: e0227078

---

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Masaki K
Current Eye Research 2020; 0: 1-10

---

84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Nakamura M
Scientific reports 2019; 9: 19288

---

84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Nakazawa T
PLoS ONE 2019; 14: e0227078

---

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Nakazawa T
Current Eye Research 2020; 0: 1-10

---

84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shiga Y; Tsuda S; Omodaka K; Saya H; Nakazawa T
Scientific reports 2019; 9: 19288

---